Dr. Alexander Khalessi is leading efforts to protect NIH funding amid proposed cuts that could disrupt critical research. These changes threaten breakthroughs in neuroscience, cancer, and other vital fields.
Dr. Alexander Khalessi, chair of UC San Diego's Department of Neurological Surgery, is leading efforts to protect NIH funding amid proposed restrictions that could strain research budgets. These changes include capping indirect costs for NIH grants at 15%, impacting infrastructure like administration and facilities.
Dr. Khalessi warns that such cuts could disrupt vital research in areas like cancer immunotherapy and neuroscience, delaying breakthroughs for diseases such as Alzheimer's and Parkinson's. Reduced funding may also drive top scientific talent away, undermining U.S. leadership in medical innovation.
As chair of AANS and CNS, Dr. Khalessi advocates for sustainable NIH funding to support life-saving research and medical progress. Recent executive orders have put California's research funding in jeopardy, risking over $6 billion in federal support. His leadership highlights the need for robust NIH funding to continue groundbreaking scientific work.
